Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays the completed HIV-1 dose-ranging study record, including its treatment arms, eligibility criteria, locations, and reported outcome measures, instead of an access-denied error.
    Difference
    100%
    Check dated 2026-11-08T14:09:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site’s footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:42:17.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:22:22.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:54.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier advanced from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:29.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    A 403 Forbidden message and a Home link appear in place of the study content, indicating the study record could not be displayed.
    Difference
    0.5%
    Check dated 2026-10-04T20:56:48.000Z thumbnail image

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.